Literature DB >> 28596336

Regenerating optic pathways from the eye to the brain.

Bireswar Laha1, Ben K Stafford1, Andrew D Huberman2,3,4.   

Abstract

Humans are highly visual. Retinal ganglion cells (RGCs), the neurons that connect the eyes to the brain, fail to regenerate after damage, eventually leading to blindness. Here, we review research on regeneration and repair of the optic system. Intrinsic developmental growth programs can be reactivated in RGCs, neural activity can enhance RGC regeneration, and functional reformation of eye-to-brain connections is possible, even in the adult brain. Transplantation and gene therapy may serve to replace or resurrect dead or injured retinal neurons. Retinal prosthetics that can restore vision in animal models may too have practical power in the clinical setting. Functional restoration of sight in certain forms of blindness is likely to occur in human patients in the near future.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28596336      PMCID: PMC6333302          DOI: 10.1126/science.aal5060

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  48 in total

1.  Retinal stem cells in the adult mammalian eye.

Authors:  V Tropepe; B L Coles; B J Chiasson; D J Horsford; A J Elia; R R McInnes; D van der Kooy
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

Review 2.  The relationship between neuronal survival and regeneration.

Authors:  J L Goldberg; B A Barres
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

3.  Retinal ganglion cells do not extend axons by default: promotion by neurotrophic signaling and electrical activity.

Authors:  Jeffrey L Goldberg; Juan S Espinosa; Youfeng Xu; Norman Davidson; Gregory T A Kovacs; Ben A Barres
Journal:  Neuron       Date:  2002-02-28       Impact factor: 17.173

4.  Transient up-regulation of retinal EphA3 and EphA5, but not ephrin-A2, coincides with re-establishment of a topographic map during optic nerve regeneration in goldfish.

Authors:  Carolyn E King; Amy Wallace; Jennifer Rodger; Carole Bartlett; Lyn D Beazley; Sarah A Dunlop
Journal:  Exp Neurol       Date:  2003-10       Impact factor: 5.330

5.  Leukemia inhibitory factor determines the growth status of injured adult sensory neurons.

Authors:  W B Cafferty; N J Gardiner; I Gavazzi; J Powell; S B McMahon; J K Heath; J Munson; J Cohen; S W Thompson
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

6.  Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.

Authors:  Binhai Zheng; Jasvinder Atwal; Carole Ho; Lauren Case; Xiao-lin He; K Christopher Garcia; Oswald Steward; Marc Tessier-Lavigne
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

7.  Retinal remodeling triggered by photoreceptor degenerations.

Authors:  Bryan W Jones; Carl B Watt; Jeanne M Frederick; Wolfgang Baehr; Ching-Kang Chen; Edward M Levine; Ann H Milam; Matthew M Lavail; Robert E Marc
Journal:  J Comp Neurol       Date:  2003-09-08       Impact factor: 3.215

8.  Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state.

Authors:  Dietmar Fischer; Zhigang He; Larry I Benowitz
Journal:  J Neurosci       Date:  2004-02-18       Impact factor: 6.167

Review 9.  Nogo and axon regeneration.

Authors:  Martin E Schwab
Journal:  Curr Opin Neurobiol       Date:  2004-02       Impact factor: 6.627

10.  An oligodendrocyte lineage-specific semaphorin, Sema5A, inhibits axon growth by retinal ganglion cells.

Authors:  Jeffrey L Goldberg; Mauricio E Vargas; Jack T Wang; Wim Mandemakers; Stephen F Oster; David W Sretavan; Ben A Barres
Journal:  J Neurosci       Date:  2004-05-26       Impact factor: 6.167

View more
  35 in total

1.  Regulation of UNC-40/DCC and UNC-6/Netrin by DAF-16 promotes functional rewiring of the injured axon.

Authors:  Atrayee Basu; Sibaram Behera; Smriti Bhardwaj; Shirshendu Dey; Anindya Ghosh-Roy
Journal:  Development       Date:  2021-06-10       Impact factor: 6.868

Review 2.  Monitoring Neurodegeneration in Glaucoma: Therapeutic Implications.

Authors:  Norimitsu Ban; Carla J Siegfried; Rajendra S Apte
Journal:  Trends Mol Med       Date:  2017-12-07       Impact factor: 11.951

3.  Stereotyped Synaptic Connectivity Is Restored during Circuit Repair in the Adult Mammalian Retina.

Authors:  Corinne Beier; Daniel Palanker; Alexander Sher
Journal:  Curr Biol       Date:  2018-05-24       Impact factor: 10.834

Review 4.  Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma.

Authors:  Sanaz Behtaj; Andreas Öchsner; Yuri G Anissimov; Maksym Rybachuk
Journal:  Tissue Eng Regen Med       Date:  2020-05-10       Impact factor: 4.169

Review 5.  Assembly and repair of eye-to-brain connections.

Authors:  Supraja G Varadarajan; Andrew D Huberman
Journal:  Curr Opin Neurobiol       Date:  2018-10-16       Impact factor: 6.627

6.  Ibuprofen does not inhibit RhoA-mediated growth cone collapse of embryonic chicken retinal axons by LPA.

Authors:  James Vinton; Adaeze Aninweze; Eric Birgbauer
Journal:  Exp Brain Res       Date:  2021-07-28       Impact factor: 1.972

Review 7.  Looking into the future: Gene and cell therapies for glaucoma.

Authors:  András M Komáromy; Kristin L Koehl; Shin Ae Park
Journal:  Vet Ophthalmol       Date:  2021-01-07       Impact factor: 1.644

8.  Swimming Exercise Promotes Post-injury Axon Regeneration and Functional Restoration through AMPK.

Authors:  Sandeep Kumar; Sibaram Behera; Atrayee Basu; Shirshendu Dey; Anindya Ghosh-Roy
Journal:  eNeuro       Date:  2021-06-16

Review 9.  Development of Stem Cell Therapies for Retinal Degeneration.

Authors:  Emma L West; Joana Ribeiro; Robin R Ali
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-08-03       Impact factor: 9.708

Review 10.  Cell Replacement Therapy for Retinal and Optic Nerve Diseases: Cell Sources, Clinical Trials and Challenges.

Authors:  Rosa M Coco-Martin; Salvador Pastor-Idoate; Jose Carlos Pastor
Journal:  Pharmaceutics       Date:  2021-06-11       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.